Sign in

CIK 0001720580

  • Non-accelerated filer
  • Smaller reporting company

Adicet Bio, Inc.

Sign in to watch
Ticker
ACET
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 26
Incorporated
DE
Entity type
Operating
EIN
813305277
Phone
+1 617-482-2333
Business address
131 DARTMOUTH STREET, 3RD FLOOR, BOSTON, MA, 02116
Former names
resTORbio, Inc.
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 50 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-03-16 Schor Chen President and CEO Sale −2,508 $15.07 $38K 152,710
2021-03-16 Schor Chen President and CEO Sale −2,089 $15.66 $33K 127,229
2021-03-16 Schor Chen President and CEO Sale −6,474 $15.07 $98K 155,218
2021-03-16 Schor Chen President and CEO Sale −5,395 $15.66 $84K 129,318
2021-03-16 Schor Chen President and CEO Sale −2,508 $15.07 $38K 152,710
2021-03-16 Schor Chen President and CEO Sale −2,089 $15.66 $33K 127,229
2021-03-02 Sinclair Andrew Director Grant or award · Stock Option (Right to Buy) +28,828 28,828
2021-03-02 Sinclair Andrew Director Grant or award · Stock Option (Right to Buy) +28,828 28,828
2021-02-12 Chimovits Erez Director Grant or award +420,299 $13.00 $5.5M 5,243,259
2021-02-12 Chimovits Erez Director Grant or award +104,050 $13.00 $1.4M 396,657
2021-02-12 GORDON CARL L Director Grant or award +420,299 $13.00 $5.5M 5,243,259
2021-02-12 GORDON CARL L Director Grant or award +104,050 $13.00 $1.4M 396,657
2021-02-12 ORBIMED ADVISORS LLC Director Grant or award +420,299 $13.00 $5.5M 5,243,259
2021-02-12 ORBIMED ADVISORS LLC Director Grant or award +104,050 $13.00 $1.4M 396,657
2021-02-12 ABBOT STEWART Grant or award · Stock Option (Right to Buy) +106,900 106,900
2021-02-12 Klickstein Lloyd Chief Innovation Officer Grant or award · Stock Option (Right to Buy) +41,100 41,100
2021-02-12 Harvey Brian Nicholas Chief Financial Officer Grant or award · Stock Option (Right to Buy) +28,200 28,200
2021-02-12 Healey Don Chief Technology Officer Grant or award · Stock Option (Right to Buy) +30,400 30,400
2021-02-12 Krehlik Carrie Chief Human Resources Officer Grant or award · Stock Option (Right to Buy) +11,200 11,200
2021-02-12 Schor Chen President and CEO Grant or award · Stock Option (Right to Buy) +421,600 421,600

Page 23 of 24 · 478 trades